Scarica l'app Stockscreener
5.96
4.01%
0.23
Dopo l'orario di chiusura:
5.96
Precedente Chiudi:
$5.73
Aprire:
$5.68
Volume 24 ore:
174.81K
Relative Volume:
1.50
Capitalizzazione di mercato:
$339.41M
Reddito:
-
Utile/perdita netta:
$-66.86M
Rapporto P/E:
-4.9667
EPS:
-1.2
Flusso di cassa netto:
$-58.82M
1 W Prestazione:
+12.67%
1M Prestazione:
+56.02%
6M Prestazione:
+31.86%
1 anno Prestazione:
+26.00%
Intervallo 1D:
$5.59
$6.05
Intervallo di 1 settimana:
$5.095
$6.05
Portata 52W:
$2.60
$7.77
Design Therapeutics Inc Stock (DSGN) Company Profile
Nome
Design Therapeutics Inc
Settore
Industria
Telefono
858-293-4900
Indirizzo
6005 HIDDEN VALLEY ROAD, CARLSBAD
Confronta DSGN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
DSGN
Design Therapeutics Inc
|
5.96 | 326.31M | 0 | -66.86M | -58.82M | -1.20 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.62 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.80 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
447.43 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
722.01 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
336.26 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Design Therapeutics Inc Stock (DSGN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-05-07 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2023-11-14 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2023-08-15 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2023-08-15 | Downgrade | SVB Securities | Outperform → Market Perform |
| 2023-08-15 | Downgrade | Wedbush | Outperform → Neutral |
| 2023-05-04 | Aggiornamento | Goldman | Sell → Neutral |
| 2022-06-10 | Iniziato | Wedbush | Outperform |
| 2022-05-02 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-01-19 | Iniziato | Goldman | Sell |
| 2021-04-20 | Iniziato | Goldman | Neutral |
| 2021-04-20 | Iniziato | Piper Sandler | Overweight |
| 2021-04-20 | Iniziato | SVB Leerink | Outperform |
Mostra tutto
Design Therapeutics Inc Borsa (DSGN) Ultime notizie
Is Design Therapeutics Inc. a good stock for dollar cost averagingJuly 2025 Market Mood & Low Risk Profit Maximizing Plans - khodrobank.com
Published on: 2025-09-03 12:30:21 - Newser
Applying big data sentiment scoring on Design Therapeutics Inc.Bull Run & Consistent Return Strategy Ideas - Newser
Combining machine learning predictions for Design Therapeutics Inc.M&A Rumor & Technical Pattern Based Signals - Newser
Understanding Design Therapeutics Inc.’s price movementWeekly Profit Report & Safe Entry Point Identification - Newser
Tools to assess Design Therapeutics Inc.’s risk profileMarket Trend Report & Fast Momentum Stock Entry Tips - Newser
Pattern recognition hints at Design Therapeutics Inc. upside2025 Trading Recap & Verified Swing Trading Watchlists - Newser
Can swing trading help recover from Design Therapeutics Inc. lossesIndex Update & High Conviction Buy Zone Alerts - Newser
Historical volatility pattern of Design Therapeutics Inc. visualized2025 Volatility Report & Weekly Hot Stock Watchlists - Newser
Is Design Therapeutics Inc. stock reversal real or fakeJuly 2025 Institutional & High Win Rate Trade Tips - Newser
Has Design Therapeutics Inc. formed a bullish divergenceTrade Entry Report & Smart Money Movement Tracker - Newser
Using data models to predict Design Therapeutics Inc. stock movementWeekly Risk Summary & Real-Time Chart Pattern Alerts - Newser
Can a trend reversal in Design Therapeutics Inc. lead to recoveryPortfolio Gains Report & Safe Swing Trade Setups - Newser
Can Design Therapeutics Inc. deliver alphaJuly 2025 Setups & Free Low Drawdown Momentum Trade Ideas - khodrobank.com
Design Therapeutics, Inc. shares rise 3.98% intraday after Twist Bioscience collaboration for novel antibody-drug conjugates. - AInvest
Published on: 2025-09-02 20:32:38 - khodrobank.com
Wellington Management Group LLP Purchases Shares of 141,519 Design Therapeutics, Inc. $DSGN - Defense World
Can Design Therapeutics Inc. expand its profit marginsEntry Point & Reliable Volume Spike Alerts - khodrobank.com
Is it too late to sell Janux Therapeutics Inc.Treasury Yields & Community Verified Trade Alerts - Newser
Is Design Therapeutics Inc. currently under institutional pressureMarket Growth Summary & High Conviction Buy Zone Picks - khodrobank.com
Visual trend scoring systems applied to Design Therapeutics Inc.Forecast Cut & Stock Market Timing Techniques - Newser
Will breakout in Design Therapeutics Inc. lead to full recoveryJuly 2025 Rallies & AI Powered Market Entry Strategies - Newser
Long term hold vs stop loss in Design Therapeutics Inc.2025 Earnings Impact & Short-Term High Return Ideas - Newser
What momentum shifts mean for Design Therapeutics Inc.Weekly Trend Summary & Verified Momentum Stock Ideas - Newser
Advanced analytics toolkit walkthrough for Design Therapeutics Inc.Weekly Stock Report & High Accuracy Trade Alerts - Newser
Will Design Therapeutics Inc. stock recover after recent drop2025 Historical Comparison & Precise Swing Trade Entry Alerts - Newser
How to build a custom watchlist for Design Therapeutics Inc.Weekly Market Outlook & Smart Investment Allocation Tips - Newser
Why Design Therapeutics Inc. is moving todayJuly 2025 Market Mood & High Accuracy Trade Signal Alerts - Newser
Will a bounce in Design Therapeutics Inc. offer an exit2025 Year in Review & Daily Profit Maximizing Tips - Newser
Steven Cohen Takes Bold Biotech Bets With Invivyd and Design Therapeutics - AInvest
Steven Cohen's Biotech Bets Are Getting Bolder — And Smaller - inkl
Design Therapeutics Inc Azioni (DSGN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.14%
1.34%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):